Search

everythinglearnresearchcommunity

for

Search:↓

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Females have higher Dechlorane Plus in hair, while males have more in dorm dust.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Testosterone treatment may affect heart response to stress in transgender men.

Hair restoration helps transgender patients achieve desired gender appearances.

Feminizing hormone therapy increases kidney filtration rate.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

General surgeons are crucial for handling various emergencies in small hospitals and should balance broad skills with some specialization for effective, economical community care.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Bicalutamide improved hair growth more than spironolactone in women with hair loss.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Cultural and national factors shape gender roles in advertising, highlighting the need for inclusive, gender-sensitive language.

Prolactin may affect hair growth differently based on gender and scalp area.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Genetics may play a significant role in gender dysphoria.